BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 30616389)

  • 1. Interleukin-35 suppresses antitumor activity of circulating CD8
    Liu MX; Liu QY; Liu Y; Cheng ZM; Liu L; Zhang L; Sun DH
    Connect Tissue Res; 2019 Jul; 60(4):367-375. PubMed ID: 30616389
    [No Abstract]   [Full Text] [Related]  

  • 2. Interleukin-35 Suppresses Antiviral Immune Response in Chronic Hepatitis B Virus Infection.
    Shao X; Ma J; Jia S; Yang L; Wang W; Jin Z
    Front Cell Infect Microbiol; 2017; 7():472. PubMed ID: 29181338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-35 Dampens CD8
    Yang L; Shao X; Jia S; Zhang Q; Jin Z
    Front Immunol; 2019; 10():1032. PubMed ID: 31134088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-35 Suppresses the Antitumor Activity of T Cells in Patients with Non-Small Cell Lung Cancer.
    Wang HM; Zhang XH; Feng MM; Qiao YJ; Ye LQ; Chen J; Fan FF; Guo LL
    Cell Physiol Biochem; 2018; 47(6):2407-2419. PubMed ID: 29991058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The modulatory activity of T cell immunoglobulin and mucin domain-containing protein 3 on T lymphocytes in patients with chronic heart failure].
    Yu HW; Dong YY; Dang YH
    Zhonghua Yi Xue Za Zhi; 2020 May; 100(17):1315-1319. PubMed ID: 32375439
    [No Abstract]   [Full Text] [Related]  

  • 6. Interleukin-35 Suppresses CD8
    Yang L; Zhang Q; Song J; Wang W; Jin Z
    Dig Dis Sci; 2020 Dec; 65(12):3614-3623. PubMed ID: 31974915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-7 promotes CD8
    Tian X; Su Z; Guo S; Wang C; Zhang X; Du J
    Int Immunopharmacol; 2019 Oct; 75():105773. PubMed ID: 31349155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-7 enhances anti-tumor activity of CD8
    Teng D; Ding L; Cai B; Luo Q; Wang H
    Cytokine; 2019 Jun; 118():115-123. PubMed ID: 29655570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Augmentation of effector CD8+ T cell generation with enhanced granzyme B expression by IL-27.
    Morishima N; Owaki T; Asakawa M; Kamiya S; Mizuguchi J; Yoshimoto T
    J Immunol; 2005 Aug; 175(3):1686-93. PubMed ID: 16034109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-35 regulates peripheral T cell activity in patients with Kawasaki disease.
    Sun M; Xing H
    Int Immunopharmacol; 2021 Jul; 96():107642. PubMed ID: 33862556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-35 has a Protective Role in Infectious Mononucleosis-Induced Liver Inflammation Probably by Inhibiting CD8
    Gao Y; Li L; Hu X; Zhang W; Li Y
    Arch Immunol Ther Exp (Warsz); 2022 Oct; 70(1):25. PubMed ID: 36219249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-36 receptor antagonist stimulation in vitro inhibits peripheral and lung-resident T cell response isolated from patients with ventilator-associated pneumonia.
    Xin T; Xing R; Jiang H; Jin F; Li M
    Int Immunopharmacol; 2024 Mar; 129():111513. PubMed ID: 38301411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of interleukin-7 on the anti-tumor function of CD8(+) T cells in patients with non-small cell lung cancer].
    Zhang XH; Wang HM; Jin L; Chang R; Zu FC; Li FZ; Ku CY
    Zhonghua Yi Xue Za Zhi; 2018 Aug; 98(30):2429-2433. PubMed ID: 30138989
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical significance of ascitic interleukin-7 expression levels in cirrhotic patients complicated with spontaneous bacterial peritonitis].
    Hou HR; Pan HH; Li YK; Wei JF; Kang YH; Mao CS; Shang J; Kang Y
    Zhonghua Gan Zang Bing Za Zhi; 2019 Apr; 27(4):274-280. PubMed ID: 31082338
    [No Abstract]   [Full Text] [Related]  

  • 15. Interleukin-7 augments CD8
    Hou H; Kang Y; Zeng Y; Li Y; Shang J
    Cytokine; 2018 Feb; 102():26-33. PubMed ID: 29275010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tim3/Gal9 interactions between T cells and monocytes result in an immunosuppressive feedback loop that inhibits Th1 responses in osteosarcoma patients.
    Li X; Chen Y; Liu X; Zhang J; He X; Teng G; Yu D
    Int Immunopharmacol; 2017 Mar; 44():153-159. PubMed ID: 28103502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-36gamma Mediates the
    Zhou Y; Chen J; Bai S; Yang F; Yan R; Song Y; Yang B; Li C; Wang J
    Viral Immunol; 2024; 37(1):24-35. PubMed ID: 38301135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-37 suppresses the cytotoxicity of hepatitis B virus peptides-induced CD8+ T cells in patients with acute hepatitis B.
    Liu Q; Zhou Q; Wang M; Pang B
    Biomol Biomed; 2023 May; 23(3):527-534. PubMed ID: 36326182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of Interleukin 21 Reduction in Osteosarcoma Patients Due to PD-1/PD-L1-Mediated Suppression of Follicular Helper T Cell Functionality.
    Gao W; Zhou J; Ji B
    DNA Cell Biol; 2017 Sep; 36(9):794-800. PubMed ID: 28650673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Th9 cells promote antitumor immunity via IL-9 and IL-21 and demonstrate atypical cytokine expression in breast cancer.
    You FP; Zhang J; Cui T; Zhu R; Lv CQ; Tang HT; Sun DW
    Int Immunopharmacol; 2017 Nov; 52():163-167. PubMed ID: 28918288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.